The Sackler family, the billionaire owners of OxyContin maker Purdue Pharma, have secured immunity from all current and future civil litigation related to their role in fueling the opioid epidemic. The legal shield was granted last week by a federal appeals court in exchange for the family agreeing to pay up to $6 billion to thousands of plaintiffs in various lawsuits that are now suspended as part of the deal. While the Sacklers appear safe from further civil litigation, they could — and should — be criminally charged, says Ed Bisch, who lost his son Eddie to an OxyContin-related overdose in 2001 at age 18. “Fines without any prosecutions, there is no deterrent. They look at it as the cost of doing business,” says Bisch. We also speak to Christopher Glazek, the investigative reporter who was the first to publicly report how the Sackler family had significantly profited from selling OxyContin while fully aware that the highly addictive drug was directly fueling the opioid epidemic in America. “The Sacklers lied about how addictive the drug was, in order to convince doctors and patients that it wasn’t dangerous,” says Glazek.